Search results
Results from the WOW.Com Content Network
Australia spends more than $2 billion annually treating cancer, [35] with skin cancer the most costly. From 2005-15 over $300 million was spent annually on diagnosis, treatment and pathology-related costs of skin cancer. With $512.3 million spent in 2010 on melanoma carcinomas, [22] costs continued to rise.
Australia has the highest per capita incidence of melanoma in the world. [ 77 ] Although the rates of many cancers in the United States is falling, the incidence of melanoma keeps growing, with approximately 68,729 melanomas diagnosed in 2004 according to reports of the National Cancer Institute .
Melanoma is the most dangerous type of skin cancer; it develops from the melanin -producing cells known as melanocytes. [ 1 ] It typically occurs in the skin, but may rarely occur in the mouth, intestines, or eye (uveal melanoma). [ 1 ][ 2 ] In women, melanomas most commonly occur on the legs; while in men, on the back. [ 2 ]
Melanoma, meanwhile, is a type of skin cancer that can spread to other areas of the body. The main cause of both is exposure to ultraviolet rays, which come from the sun and are used in tanning beds.
Superficial spreading melanoma (SSM) is a type of skin cancer that typically starts as an irregularly edged dark spot typically on sun-exposed part of the body. [2][3] The colour may be variable with dark, light and reddish shades; occasionally no color at all. [2] It typically grows in diameter before spreading to deeper tissue, forming a bump ...
Whether or not a skin self-check will help spot cancer early depends on a lot of factors, like the type of cancer it is and how the check is done. Some experts believe that self-checks can be ...
A study shows that men are more susceptible to melanoma, as they are less informed about sun damage than women. Why melanoma is so deadly for men, and why it doesn’t have to be Skip to main content
Long is a medical oncologist specialising in melanoma. She has led numerous clinical trials, [7] focusing on targeted therapies and immuno-oncology in melanoma. She is the chief investigator on research into the molecular biology of melanoma. [8] Long is co-director of the Melanoma Institute Australia with pathologist Richard Scolyer.